UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 04/2019, Volume 380, Issue 17, pp. 1597 - 1605
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Immune Reconstitution Inflammatory Syndrome - etiology | Brain - diagnostic imaging | Humans | Middle Aged | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | CD4-Positive T-Lymphocytes - physiology | Viral Load | Adult | Female | Leukoencephalopathy, Progressive Multifocal - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Down-Regulation | Leukoencephalopathy, Progressive Multifocal - drug therapy | Programmed Cell Death 1 Receptor - metabolism | Cerebrospinal Fluid - virology | CD8-Positive T-Lymphocytes - physiology | White Matter - pathology | Magnetic Resonance Imaging | White Matter - diagnostic imaging | JC Virus - isolation & purification | Lymphocyte Count | Aged | Leukoencephalopathy, Progressive Multifocal - diagnostic imaging | Immunologic Factors - therapeutic use | Drug therapy | Leukoencephalopathy | Nuclear magnetic resonance--NMR | PD-1 protein | Laboratories | CD8 antigen | Body weight | Immune clearance | Infections | Cerebrospinal fluid | Progressive multifocal leukoencephalopathy | Disability | Pembrolizumab | Lymphocytes | Peripheral blood | Drug dosages | Movement disorders | Antigens | Immune response | Cytokines | Patients | Lymphoma | CD4 antigen | Immune checkpoint | Cell death | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Neurology, ISSN 0028-3878, 05/2011, Volume 76, Issue 20, pp. 1697 - 1704
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Predictive Value of Tests | Prognosis | Natalizumab | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Cause of Death | Socioeconomic Factors | Antibodies, Monoclonal, Humanized | Karnofsky Performance Status | Anti-Inflammatory Agents - therapeutic use | Product Surveillance, Postmarketing | Adult | Female | Mitoxantrone - therapeutic use | Disability Evaluation | Treatment Outcome | Leukoencephalopathy, Progressive Multifocal - mortality | Multiple Sclerosis - complications | Magnetic Resonance Imaging | Survival Analysis | Leukoencephalopathy, Progressive Multifocal - etiology | Early Diagnosis | Multiple Sclerosis - drug therapy | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2013, Volume 369, Issue 2, pp. 197 - 198
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Janus Kinases - antagonists & inhibitors | Primary Myelofibrosis - drug therapy | Primary Myelofibrosis - complications | Humans | Brain - pathology | Leukoencephalopathy, Progressive Multifocal - etiology | Male | Aged | Pyrazoles - adverse effects | Nuclear magnetic resonance--NMR | Myelofibrosis | Biopsy | Ataxia | Janus kinase | Leukoencephalopathy | Progressive multifocal leukoencephalopathy | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 11, pp. 1081 - 1087
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Infectious diseases | Viral diseases | Biological and medical sciences | Viral diseases of the nervous system | Medical sciences | Human viral diseases | Leukoencephalopathy, Progressive Multifocal - immunology | Immune Reconstitution Inflammatory Syndrome - etiology | JC Virus - immunology | Natalizumab | JC Virus - genetics | Humans | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Integrin alpha4 - immunology | DNA, Viral - blood | Multiple Sclerosis - complications | Antibodies, Monoclonal, Humanized | Leukoencephalopathy, Progressive Multifocal - chemically induced | Magnetic Resonance Imaging | Polymerase Chain Reaction | Brain - pathology | Multiple Sclerosis - pathology | Adult | Multiple Sclerosis - drug therapy | Case studies | Multiple sclerosis | Care and treatment | Diagnosis | Leukoencephalopathy, Progressive multifocal | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Emerging infectious diseases, ISSN 1080-6040, 08/2018, Volume 24, Issue 8, pp. 1594 - 1596
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Hodgkin Disease - diagnostic imaging | Hodgkin Disease - virology | Antineoplastic Agents, Immunological - administration & dosage | Hodgkin Disease - pathology | Humans | Middle Aged | Hydrocortisone - therapeutic use | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Hodgkin Disease - drug therapy | Female | Leukoencephalopathy, Progressive Multifocal - virology | Nivolumab - adverse effects | Magnetic Resonance Imaging | Antineoplastic Agents, Immunological - adverse effects | Viremia - pathology | Viremia - virology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | JC Virus - isolation & purification | Leukoencephalopathy, Progressive Multifocal - etiology | Viremia - diagnostic imaging | Aged | Leukoencephalopathy, Progressive Multifocal - diagnostic imaging | Leukoencephalopathy, Progressive Multifocal - pathology | Programmed Cell Death 1 Receptor - immunology | Viremia - etiology | Programmed Cell Death 1 Receptor - genetics | Nivolumab - administration & dosage | Care and treatment | Immunotherapy | Leukoencephalopathy, Progressive multifocal | Monoclonal antibodies | Lymphomas | T cells | Health aspects | Apoptosis | Index Medicus | immune checkpoint inhibitor | viruses | nivolumab | HIV | progressive multifocal leukoencephalopathy | JC virus | encephalitis | AIDS and other retroviruses | meningtitis | Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab | Research Letter | meningtitis/encephalaitis
Journal Article
Annals of neurology, ISSN 0364-5134, 2011, Volume 70, Issue 2, pp. 305 - 322
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Humans | Middle Aged | Risk Factors | Transplants - adverse effects | Leukoencephalopathy, Progressive Multifocal - virology | Male | Survival Rate | Leukoencephalopathy, Progressive Multifocal - diagnosis | PubMed | Young Adult | JC Virus | Adolescent | Leukoencephalopathy, Progressive Multifocal - etiology | Adult | Female | Aged | Retrospective Studies | Cohort Studies | Confidence intervals | Bone marrow | Transplants & implants | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
Annual review of medicine, ISSN 0066-4219, 02/2010, Volume 61, Issue 1, pp. 35 - 47
Cell tropism factors | Immune system dysfunction | Viral latency and reactivation | Demyelination | Biological therapies for autoimmune diseases | Immunomodulation | Virus Latency | Humans | Autoimmune Diseases - complications | Autoimmune Diseases - therapy | Leukoencephalopathy, Progressive Multifocal - etiology | JC Virus - physiology | Leukoencephalopathy, Progressive Multifocal - pathology | Autoimmune Diseases - pathology | Usage | Care and treatment | Immunotherapy | Leukoencephalopathy, Progressive multifocal | Monoclonal antibodies | Causes of | Diagnosis | Health aspects | Neurology | Viruses | Medical treatment | Brain diseases | Cell adhesion & migration | Index Medicus
Journal Article
Lancet neurology, ISSN 1474-4422, 2010, Volume 9, Issue 4, pp. 438 - 446
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Antibodies, Monoclonal, Humanized | Leukoencephalopathy, Progressive Multifocal - therapy | Natalizumab | Humans | Antibodies, Monoclonal - adverse effects | Leukoencephalopathy, Progressive Multifocal - etiology | Antibodies, Monoclonal - therapeutic use | Immunologic Factors - adverse effects | Leukoencephalopathy, Progressive Multifocal - diagnosis | Leukoencephalopathy, Progressive Multifocal - epidemiology | Immunologic Factors - therapeutic use | Multiple Sclerosis - drug therapy | Medical colleges | Multiple sclerosis | Care and treatment | Leukoencephalopathy, Progressive multifocal | Index Medicus | Cerebrospinal fluid
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 1/2009, Volume 199, Issue 1, pp. 77 - 83
Polymerase chain reaction | HIV/AIDS | Highly active antiretroviral therapy | HIV infections | Neurologic manifestations | HIV | JC virus | Mortality | AIDS | Symptoms | Progressive multifocal leukoencephalopathy | Fundamental and applied biological sciences. Psychology | Miscellaneous | Infectious diseases | Microbiology | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Viral diseases of the nervous system | Medical sciences | Human viral diseases | Virology | Demography | Leukoencephalopathy, Progressive Multifocal - prevention & control | Humans | Male | Incidence | Speech Disorders - etiology | Cognition Disorders - etiology | Female | Risk Factors | Treatment Outcome | CD4 Lymphocyte Count | Leukoencephalopathy, Progressive Multifocal - mortality | Antiretroviral Therapy, Highly Active | Seizures - epidemiology | Speech Disorders - epidemiology | HIV Infections - complications | Seizures - etiology | Survival Analysis | Denmark - epidemiology | HIV Infections - drug therapy | Vision Disorders - epidemiology | Cognition Disorders - epidemiology | Leukoencephalopathy, Progressive Multifocal - epidemiology | Cohort Studies | Vision Disorders - etiology | Development and progression | Research | Patient outcomes | Leukoencephalopathy, Progressive multifocal | Distribution | Index Medicus | Abridged Index Medicus
Journal Article
Lancet neurology, ISSN 1474-4422, 05/2018, Volume 17, Issue 5, pp. 467 - 480
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Leukoencephalopathy, Progressive Multifocal - immunology | Leukoencephalopathy, Progressive Multifocal - chemically induced | Humans | Natalizumab - adverse effects | Leukoencephalopathy, Progressive Multifocal - etiology | Leukoencephalopathy, Progressive Multifocal - virology | Immunologic Factors - adverse effects | Multiple Sclerosis - drug therapy | Medical colleges | Medical research | Neurosciences | Multiple sclerosis | Medicine, Experimental | Disease susceptibility | Drug therapy | Molecular biology | Health aspects | Leukoencephalopathy | Brain | Disease | Immunomodulation | Pathogenesis | Central nervous system | Infections | Patients | Progressive multifocal leukoencephalopathy | Magnetic resonance imaging | Surveillance | Demyelination | Binding sites | Deoxyribonucleic acid--DNA | Immune system | Index Medicus
Journal Article
Drug safety, ISSN 0114-5916, 2010, Volume 33, Issue 11, pp. 969 - 983
Polyomavirus-infections | Natalizumab, adverse reactions | Monoclonal-antibodies, adverse reactions | Efalizumab, adverse reactions | Progressive-multifocal- leukoencephalopathy, pathogenesis | Progressive-multifocal-leukoencephalopathy, drug-induced | Demyelinating-disorders, drug-induced | Mycophenolate-mofetil, adverse reactions | Rituximab, adverse reactions | Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Toxicology | Life Sciences & Biomedicine | Science & Technology | JC Virus - immunology | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Leukoencephalopathy, Progressive Multifocal - drug therapy | Leukoencephalopathy, Progressive Multifocal - virology | Antibodies, Monoclonal - therapeutic use